Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
- DOI
- 10.1186/s12902-020-00667-5
- Published
- 2021 Jan 7
- Container
- BMC endocrine disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12902-020-00667-5,
title = {Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.},
author = {Quak E and Lasne Cardon A and Ciappuccini R and Lasnon C and Bastit V and Le Henaff V and Lireux B and Foucras G and Jaudet C and Berchi C and Grellard JM and Lequesne J and Clarisse B and Bardet S},
year = {2021},
journal = {BMC endocrine disorders},
doi = {10.1186/s12902-020-00667-5},
url = {https://doi.org/10.1186/s12902-020-00667-5}
}RIS
TY - JOUR TI - Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2. AU - Quak E AU - Lasne Cardon A AU - Ciappuccini R AU - Lasnon C AU - Bastit V AU - Le Henaff V AU - Lireux B AU - Foucras G AU - Jaudet C AU - Berchi C AU - Grellard JM AU - Lequesne J AU - Clarisse B AU - Bardet S PY - 2021 JO - BMC endocrine disorders DO - 10.1186/s12902-020-00667-5 UR - https://doi.org/10.1186/s12902-020-00667-5 ER -
APA
E, Q., A, L. C., R, C., C, L., V, B., V, L. H., B, L., G, F., C, J., C, B., JM, G., J, L., B, C., & S, B. (2021). Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.. BMC endocrine disorders. https://doi.org/10.1186/s12902-020-00667-5
Source records
- pubmed · retrieved 2026-09-25T20:10:21.719Z